Understanding Lupus – Demographics, Diagnosis, and Breakthrough Treatments
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Title: Understanding Lupus – Demographics, Diagnosis, and Breakthrough Treatments
Episode Summary: Lupus is one of the most complex autoimmune diseases—but science is changing the game. In this episode of Talking in the Woods, host Christopher Wood explains lupus in plain language: what it is, who it affects, and how doctors diagnose it. Plus, we explore cutting-edge treatments that offer hope for patients.
What You’ll Learn in This Episode:
- What lupus is and how it affects the body
- Key demographics and why ethnicity matters in treatment
- How lupus is diagnosed: ANA, anti-dsDNA, and anti-Smith tests
- SLEDAI scoring and why it’s important
- Breakthrough therapies: CAR T-cell therapy, B-cell targeting drugs, and clinical trial pipeline
- Lifestyle tips to reduce flares and improve quality of life
- Real patient story: Sierra’s journey to remission
Resources Mentioned
- Lupus Foundation of America: https://www.lupus.org
- Clinical Trials: https://clinicaltrials.gov
- CAR T-cell Therapy Case Study: Nature Medicine
References
- Patient Story – Sierra’s Journey to Remission Case Study: “CAR T-Cell Therapy in Refractory Systemic Lupus Erythematosus.” Published in Nature Medicine, 2022. Read the full article: https://www.nature.com/articles/s41591-022-02073-9
- Podcast Series Reference Talking in the Woods – Science Behind the Script: From Lab to Life. Explore all episodes:
- Future Therapies & Clinical Pipeline Fanouriakis A, et al. “Update on the Management of Systemic Lupus Erythematosus.” Published in Annals of the Rheumatic Diseases, 2023. Read the full article: https://ard.bmj.com/content/early/2023
🎧 Listen now to explore lupus from symptoms to science—and discover the future of treatment.
Pas encore de commentaire